Sunny Pharmtech Inc. (TPEX:6676)
17.75
-0.10 (-0.56%)
Mar 3, 2026, 2:59 PM CST
Sunny Pharmtech Revenue
Sunny Pharmtech had revenue of 105.73M TWD in the half year ending June 30, 2025, a decrease of -40.39%. This brings the company's revenue in the last twelve months to 290.18M, down -40.17% year-over-year. In the year 2024, Sunny Pharmtech had annual revenue of 418.01M, down -2.52%.
Revenue (ttm)
290.18M
Revenue Growth
-40.17%
P/S Ratio
9.10
Revenue / Employee
1.84M
Employees
158
Market Cap
2.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 418.01M | -10.82M | -2.52% |
| Dec 31, 2023 | 428.83M | 69.24M | 19.26% |
| Dec 31, 2022 | 359.59M | 118.59M | 49.21% |
| Dec 31, 2021 | 241.00M | -178.94M | -42.61% |
| Dec 31, 2020 | 419.94M | 185.46M | 79.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.96B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Synbio Tech | 1.00B |
| 3D Global Biotech | 324.87M |
| G&E Herbal Biotechnology | 311.78M |
| HeXun Biosciences | 290.83M |
| Gwo Xi Stem Cell Applied Technology Co. , | 184.91M |